Ligand Pharmaceuticals (LGND) Net Cash Flow (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Ligand Pharmaceuticals | 4.61 Bn | 3.83 Bn | 48.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -265.43% |
| Dec 31, 2025 | -47.84% |
| Sep 30, 2025 | 244.26% |
| Jun 30, 2025 | 179.56% |
| Mar 31, 2025 | -347.15% |
| Dec 31, 2024 | -77.31% |
| Sep 30, 2024 | 241.15% |
| Jun 30, 2024 | -217.74% |
| Mar 31, 2024 | 776.58% |
| Dec 31, 2023 | 136.05% |
| Sep 30, 2023 | 85.76% |
| Jun 30, 2023 | -237.88% |
| Mar 31, 2023 | 6.93% |
| Dec 31, 2022 | 3,612.89% |
| Sep 30, 2022 | 88.02% |
| Jun 30, 2022 | -114.46% |
| Mar 31, 2022 | -15.92% |
| Dec 31, 2021 | -374.56% |
| Sep 30, 2021 | 113.96% |
| Jun 30, 2021 | 35.37% |
| Mar 31, 2021 | 96.15% |
| Dec 31, 2020 | -219.96% |
| Sep 30, 2020 | 14,432.35% |
| Jun 30, 2020 | -105.16% |
| Mar 31, 2020 | 129.93% |
| Dec 31, 2019 | -221.33% |
| Sep 30, 2019 | -117.45% |
| Jun 30, 2019 | 2,292.83% |
| Mar 31, 2019 | 68.02% |
| Dec 31, 2018 | -606.14% |
| Sep 30, 2018 | -92.29% |
| Jun 30, 2018 | 230.33% |
| Mar 31, 2018 | 350.88% |
| Dec 31, 2017 | 55.91% |
| Sep 30, 2017 | -155.43% |
| Jun 30, 2017 | 711.29% |
| Mar 31, 2017 | 88.04% |
| Dec 31, 2016 | -368.84% |
| Sep 30, 2016 | -16.06% |
| Jun 30, 2016 | 145.45% |
| Mar 31, 2016 | -1,907.96% |
| Dec 31, 2015 | 125.28% |
| Sep 30, 2015 | 74.85% |
| Jun 30, 2015 | -1,134.12% |
| Mar 31, 2015 | 127.19% |
| Dec 31, 2014 | -112.32% |
| Sep 30, 2014 | 10,556.00% |
| Jun 30, 2014 | 16.52% |
| Mar 31, 2014 | -84.01% |
| Dec 31, 2013 | 415.54% |
| Sep 30, 2013 | -399.32% |
| Jun 30, 2013 | 112.06% |
| Mar 31, 2013 | -253.48% |
| Dec 31, 2012 | 421.36% |
| Sep 30, 2012 | -115.17% |
| Jun 30, 2012 | -125.29% |
| Mar 31, 2012 | -42.88% |
| Dec 31, 2011 | 502.52% |
| Sep 30, 2011 | 54.09% |
| Jun 30, 2011 | -196.46% |
| Mar 31, 2011 | 1,529.26% |
| Dec 31, 2010 | -133.45% |